CME: Updates in vaccine-preventable diseases: Meningococcal meningitis
ACCREDITATION EXPIRED: September 24, 2021
Activity Description / Statement of Need:
In this online, self-learning activity:
Meningococcal disease is a potentially severe bacterial infection caused by Neisseria meningitidis that may lead to serious sequelae and death in some even with appropriate treatment. N. meningitidis is a leading cause of bacterial meningitis and sepsis in the United States. Since the peak of the disease in the late 1990s, the incidence has declined annually and was at historic low rate of 0.11 per 100,000 population (349 cases) in the year 2017. Among the identified bacterial serogroups, B, C, and Y cause the majority of cases in the United States. Sixty percent of cases among patients 0-59 months and 50% of cases among 17-23 years of age are caused by serogroup B. Seventy-three percent of all cases among eleven year old or more are caused by serogroups C, W, or Y.
This activity has been designed for HCPs to review and update vaccination guidelines, raise awareness of gaps in practice, and improve competence and performance related to vaccination of eligible patients.
Target Audience:
The following HCPs: primary care physicians, pediatricians, and public health professionals; physician assistants, nurse practitioners, nurses, and pharmacists who practice in family medicine; and any other clinicians with an interest in or who commonly encounter patients eligible for vaccination against meningococcal disease.
Commercial Support Disclosure: This activity is supported by an educational grant from GlaxoSmithKline
Learners may participate in this activity free of charge.
Release Date: September 24, 2019 -- Expiration Date: September 24, 2021
Faculty: Shira Shafir, Ph.D., MPH
Agenda
|
Introduction, Disclosures |
|
Background: review of meningococcal disease
|
|
Vaccination
|
|
Barriers to optimal care in patients eligible for vaccination
|
|
Summary, conclusions, and best practice recap |
Learning Objectives
By the end of the session the participant will be able to:
- Recall epidemiology, clinical features, and complications of meningococcal meningitis
- Recognize high-risk groups (e.g., 16-23 years of age) and describe the importance of immunizing them
- Describe present meningococcal vaccination recommendations, and apply them to patient cases
- Describe the importance of vaccine series completion to patients in the prevention of invasive meningococcal disease caused by various serotypes
- Formulate an approaches to engaging with adolescents and young adults regarding meningococcal vaccination
Accreditation
ACCME Activity #201349112
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
Faculty Disclosure and Resolution of COI
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Shira C. Shafir, Ph.D., MPH has no relevant conflicts of interest to disclose.
Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, President of ScientiaCME, has no relevant conflicts of interest to disclose.
Instructions
- Read the learning objectives above
- Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
- View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
- Minimum participation threshold: Take the post-test. A score of 0% or higher is required to pass and proceed to the activity evaluation.
- Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.
System Requirements
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
Additional Courses That Are Related To This Activity
Novel antimicrobials and infectious disease practice: Research updates from ID Week 2019
Treating Oncology Patients During COVID-19
The problem with vaccines: Public hesitancy and refusal
Human immunodeficiency virus (HIV): Updates in care for the primary care physician